title: Long-distance and long-term follow-up of a patient with intermittent Cushing's disease by salivary cortisol measurements.
abstract: Salivary cortisol is an excellent indicator of the plasma free cortisol concentration in normal and pathological situations. We took advantage of its ease of sampling, allowing multiple collections at home, to follow the course of a patient with Cushing's disease living in North Africa. This 48-year-old woman presented with a clinically moderate hypercortisolism caused by a large basophilic pituitary adenoma. Bilateral extension to the cavernous sinuses precluded surgical therapy. She went into spontaneous remission based on clinical signs as well as biochemical findings. During the following 2 years she demonstrated intermittent relapses that were treated by radiotherapy (50 Gy), followed by ketoconazole and then o-paraprime-dichloro-diphenyl-dichloroethane (Op'DDD). After a prolonged clinical remission, Cushing's syndrome again became active. Bromocriptine was started without effect and a new treatment with Op'DDD was began. Evaluation and follow-up were performed during hospitalizations and mainly through the measurements of salivary cortisol in more than 100 samples sent from North Africa by air mail to our department in Paris. Thus we were able to demonstrate intermittent overproduction of cortisol before any treatment, with periods of normal and even low values, and to follow the efficacy of therapy and to detect the relapses. We conclude that measurement of salivary cortisol is a valuable tool in difficult clinical situations such as intermittent hypercortisolism and remoteness between the patient and hospital.
authors.affiliation: Clinique des Maladies Endocriniennes et Métaboliques, Laboratoire d'Hormonologie, Paris, France.
authors.forename: H
authors.initials: H
authors.lastname: Mosnier-Pudar
authors.forename: P
authors.initials: P
authors.lastname: Thomopoulos
authors.forename: X
authors.initials: X
authors.lastname: Bertagna
authors.forename: C
authors.initials: C
authors.lastname: Fournier
authors.forename: D
authors.initials: D
authors.lastname: Guiban
authors.forename: J P
authors.initials: JP
authors.lastname: Luton
mesh_terms: D000352:Africa, Northern; D003480:Cushing Syndrome / Q000188:drug therapy / Q000378:metabolism* / Q000532:radiotherapy; D005260:Female; D006801:Humans; D006843:Hydrocarbons, Chlorinated / Q000627:therapeutic use; D006854:Hydrocortisone / Q000032:analysis*; D007654:Ketoconazole / Q000627:therapeutic use; D008875:Middle Aged; D012008:Recurrence; D012075:Remission, Spontaneous; D012463:Saliva / Q000737:chemistry*
chemical_list: D006843:Hydrocarbons, Chlorinated; D007654:Ketoconazole; D006854:Hydrocortisone